Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00392145
Other study ID # 1000008579
Secondary ID
Status Completed
Phase Phase 4
First received June 27, 2006
Last updated April 16, 2018
Start date November 2006
Est. completion date May 2010

Study information

Verified date April 2018
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will look at children with dehydration secondary to gastroenteritis requiring IV rehydration and determine whether the proportion rehydrated after two hours is greater in the children who receive rapid intravenous rehydration (RIVR) or in the children who receive standard IV rehydration.


Description:

Despite a movement toward increased use of enteral rehydration, many children still receive prolonged IV rehydration in the emergency department (ED). These children commonly receive a single IV bolus of normal saline followed by the administration of a hypotonic solution at a maintenance rate.

The mean time spent in the ED by children receiving IV rehydration is significantly longer than the mean time required to treat all other conditions. ED overcrowding has been associated with poor outcomes, prolonged pain and suffering, and dissatisfaction. One of the solutions proposed in the American Academy of Pediatrics Policy Statement on ED overcrowding is that hospitals should strive to improve the efficiency of the care provided. One small step in this direction may be to improve our management of gastroenteritis and dehydration.


Recruitment information / eligibility

Status Completed
Enrollment 226
Est. completion date May 2010
Est. primary completion date May 2010
Accepts healthy volunteers No
Gender All
Age group 90 Days to 18 Years
Eligibility Inclusion Criteria:

- Acute gastroenteritis as determined by the supervising physician.

- Age greater than 90 days

- Dehydrated and unable to consume sufficient oral fluids to overcome their dehydration state

Exclusion Criteria:

- Weight less than 5 kg or greater than 33 kg

- Underlying disease which may limit the amount of IV fluids given,including but not limited to: hypoalbuminemic states, renal insufficiency, heart disease requiring pharmacotherapy or lesions that may predispose to congestive heart failure, hypertension, chronic lung disease (excluding asthma), diabetes mellitus, severe anemia, and chronic inflammatory disease

- Clinical suspicion by the attending physician of myocarditis or previously undiagnosed cardiac or renal disease.

- History of abdominal surgery or concern regarding an acute surgical abdomen

- Significant head, chest or abdominal trauma within the preceding 7 days

- Bilious or bloody vomitus

- Evidence of hemodynamic compromise (BP < 80 + 2 * age (yrs)) requiring > 20 mL/kg 0.9% normal saline to be administered in the 1st hour

- Bedside glucose < 2.8 mmol/L (see Section 8.3)

- Unable to provide a telephone number or unavailable for follow-up

- Previously enrolled in this trial

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Standard IV rehydration
A 20 mL/kg 0.9% normal saline bolus (maximum 999 mL) will be administered over 1 hour. This will be followed by D5-0.9% normal saline at a maintenance rate (maximum 55 mL/hr).
Rapid intravenous rehydration (RIVR)
A 60 mL/kg 0.9% normal saline bolus (maximum 999 mL) over 1 hour will be administered. This will be followed by D5-0.9% normal saline at a maintenance rate (maximum 55 mL/hr).

Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
The Hospital for Sick Children The Physicians' Services Incorporated Foundation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rehydration criteria defined by: dehydration score = 1, normal capillary refill time, normal skin turgor, normal respiratory rate 2 hours following the initiation of IV rehydration
Secondary Hospitalization 72 hours
Secondary Ability to tolerate oral rehydration Measured per 2 hour time period after consuming 5 mL/kg of liquid
Secondary Repeat ED visit 72 hours
Secondary Time (in minutes) from initiation of IV rehydration until disposition determination Determined by outcome
Secondary Attending physician discharge comfort level Two and four hours following initiation of IV rehydration
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04079543 - NPO and Patient Satisfaction in the Cath Lab N/A
Recruiting NCT06063655 - Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults N/A
Completed NCT05111392 - Hydration Dynamics and Influence of Beverage Composition Phase 1/Phase 2
Terminated NCT02486224 - Metabolomic Analysis of the Impacts of Hydration Status on Exercise Performance N/A
Recruiting NCT02249845 - Comparing the Diagnostic Accuracy of Clinical Dehydration Scales Among Small Children N/A
Completed NCT01285713 - IV Glucose for Dehydration Treatment Phase 2
Withdrawn NCT00691275 - Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration N/A
Completed NCT00360204 - Improving Health Outcomes for New Mothers and Babies Phase 3
Completed NCT00370968 - Zinc-ORS in Severe and Complicated Acute Diarrhea Phase 2/Phase 3
Completed NCT04076995 - INDIGO-2: The Effect of High Water Intake on Glucose Regulation in Low-drinkers N/A
Recruiting NCT05768789 - Buoy Electrolyte Study on Hydration Status of Active Men and Women N/A
Not yet recruiting NCT05428228 - Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults N/A
Completed NCT04997031 - Tap Water Intake and Perceptions in US Latinx Adults
Completed NCT04536324 - The Absorption Rate of Subcutaneous Infused Fluid
Completed NCT02926989 - Intravenous Fluids in Hospitalised Children Phase 4
Completed NCT04874584 - Culturally Tailored Nurse Coaching Study for Cancer Symptom Management N/A
Completed NCT02265575 - Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration Phase 2
Completed NCT02206581 - Using Hydration Monitor to Detect Changes in the Hydration Status Athletes N/A
Completed NCT01893853 - Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study) N/A
Completed NCT01503996 - Drinking Habits of Glaucoma Patients and Age Matched Controls N/A